BR112012003571A2 - método para melhorar e para avaliar a capacidade de fabricação de uma imunoglobina, método para preparar uma imunoglobulina, e, imunoglobulina variante. - Google Patents

método para melhorar e para avaliar a capacidade de fabricação de uma imunoglobina, método para preparar uma imunoglobulina, e, imunoglobulina variante.

Info

Publication number
BR112012003571A2
BR112012003571A2 BR112012003571A BR112012003571A BR112012003571A2 BR 112012003571 A2 BR112012003571 A2 BR 112012003571A2 BR 112012003571 A BR112012003571 A BR 112012003571A BR 112012003571 A BR112012003571 A BR 112012003571A BR 112012003571 A2 BR112012003571 A2 BR 112012003571A2
Authority
BR
Brazil
Prior art keywords
immunoglobulin
evaluating
enhancing
preparing
variant
Prior art date
Application number
BR112012003571A
Other languages
English (en)
Inventor
Andreas Arnell
Jesús Zurdo
José Jiménez
Rebeca Michael
Yvette Stallwood
Original Assignee
Lonza Biologics Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41171774&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR112012003571(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lonza Biologics Plc filed Critical Lonza Biologics Plc
Publication of BR112012003571A2 publication Critical patent/BR112012003571A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39591—Stabilisation, fragmentation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/52—Constant or Fc region; Isotype
    • C07K2317/522—CH1 domain
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • C07K2317/565—Complementarity determining region [CDR]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • C07K2317/567—Framework region [FR]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
BR112012003571A 2009-08-21 2010-08-20 método para melhorar e para avaliar a capacidade de fabricação de uma imunoglobina, método para preparar uma imunoglobulina, e, imunoglobulina variante. BR112012003571A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0914691.1A GB0914691D0 (en) 2009-08-21 2009-08-21 Immunoglobulin variants
US24171709P 2009-09-11 2009-09-11
PCT/GB2010/001579 WO2011021009A1 (en) 2009-08-21 2010-08-20 Variant immunoglobulins with improved manufacturability

Publications (1)

Publication Number Publication Date
BR112012003571A2 true BR112012003571A2 (pt) 2016-11-22

Family

ID=41171774

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112012003571A BR112012003571A2 (pt) 2009-08-21 2010-08-20 método para melhorar e para avaliar a capacidade de fabricação de uma imunoglobina, método para preparar uma imunoglobulina, e, imunoglobulina variante.

Country Status (16)

Country Link
US (2) US8951516B2 (pt)
EP (1) EP2467400B1 (pt)
JP (1) JP5901522B2 (pt)
KR (1) KR20120056850A (pt)
CN (2) CN106986935A (pt)
AU (1) AU2010284841A1 (pt)
BR (1) BR112012003571A2 (pt)
CA (1) CA2771465A1 (pt)
DK (1) DK2467400T3 (pt)
EA (1) EA201290063A1 (pt)
GB (1) GB0914691D0 (pt)
IL (1) IL217993A0 (pt)
MX (1) MX2012002100A (pt)
SG (2) SG10201404903XA (pt)
TW (1) TW201116626A (pt)
WO (1) WO2011021009A1 (pt)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5624276B2 (ja) 2006-03-31 2014-11-12 中外製薬株式会社 抗体の血中動態を制御する方法
JP5334319B2 (ja) 2007-09-26 2013-11-06 中外製薬株式会社 Ｃｄｒのアミノ酸置換により抗体の等電点を改変する方法
KR20220162801A (ko) 2008-04-11 2022-12-08 추가이 세이야쿠 가부시키가이샤 복수 분자의 항원에 반복 결합하는 항원 결합 분자
GB0914691D0 (en) 2009-08-21 2009-09-30 Lonza Biologics Plc Immunoglobulin variants
EP2647706B1 (en) 2010-11-30 2023-05-17 Chugai Seiyaku Kabushiki Kaisha Antigen-binding molecule capable of binding to plurality of antigen molecules repeatedly
US11236168B2 (en) 2012-08-24 2022-02-01 Chugai Seiyaku Kabushiki Kaisha Mouse FcγammaRII-specific Fc antibody
BR112015001955A2 (pt) 2012-08-24 2017-11-07 Chugai Pharmaceutical Co Ltd variante de região fc específica de fcgamariib
WO2014163101A1 (ja) 2013-04-02 2014-10-09 中外製薬株式会社 Ｆｃ領域改変体
RU2017115212A (ru) * 2014-10-24 2018-11-26 Ф. Хоффманн-Ля Рош Аг Гуманизация антител на основе междоменного угла vh-vl
KR20180054923A (ko) 2014-12-19 2018-05-24 추가이 세이야쿠 가부시키가이샤 항-마이오스타틴 항체, 변이체 Fc 영역을 함유하는 폴리펩타이드, 및 사용 방법
MX2017008978A (es) 2015-02-05 2017-10-25 Chugai Pharmaceutical Co Ltd Anticuerpos que comprenden un dominio de union al antigeno dependiente de la concentracion ionica, variantes de la region fc, antiocuerpor de union a interleucina 8 (il-8) y usos de los mismos.
EP3259285A2 (en) 2015-02-16 2017-12-27 Lonza Ltd Cl and/or ch1 mutated antibodies for drug conjugation
US11359009B2 (en) 2015-12-25 2022-06-14 Chugai Seiyaku Kabushiki Kaisha Anti-myostatin antibodies and methods of use
US10590199B2 (en) 2016-06-29 2020-03-17 Checkpoint Therapeutics, Inc. PD-L1-specific antibodies and methods of using the same
US11053308B2 (en) 2016-08-05 2021-07-06 Chugai Seiyaku Kabushiki Kaisha Method for treating IL-8-related diseases
SG10201607778XA (en) 2016-09-16 2018-04-27 Chugai Pharmaceutical Co Ltd Anti-Dengue Virus Antibodies, Polypeptides Containing Variant Fc Regions, And Methods Of Use
CN112119090B (zh) 2018-03-15 2023-01-13 中外制药株式会社 对寨卡病毒具有交叉反应性的抗登革热病毒抗体及使用方法
EP3772518A1 (en) * 2019-08-07 2021-02-10 Merus N.V. Modified human variable domains
WO2022147463A2 (en) * 2020-12-31 2022-07-07 Alamar Biosciences, Inc. Binder molecules with high affinity and/ or specificity and methods of making and use thereof

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8308235D0 (en) 1983-03-25 1983-05-05 Celltech Ltd Polypeptides
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
JPS61134325A (ja) 1984-12-04 1986-06-21 Teijin Ltd ハイブリツド抗体遺伝子の発現方法
GB8607679D0 (en) 1986-03-27 1986-04-30 Winter G P Recombinant dna product
GB9015198D0 (en) 1990-07-10 1990-08-29 Brien Caroline J O Binding substance
US5804187A (en) 1992-11-16 1998-09-08 Cancer Research Fund Of Contra Costa Modified antibodies with human milk fat globule specificity
ATE199392T1 (de) 1992-12-04 2001-03-15 Medical Res Council Multivalente und multispezifische bindungsproteine, deren herstellung und verwendung
ES2694002T3 (es) * 1999-01-15 2018-12-17 Genentech, Inc. Polipéptido que comprende una región Fc de IgG1 humana variante
PE20020574A1 (es) * 2000-12-06 2002-07-02 Wyeth Corp Anticuerpos humanizados que reconocen el peptido amiloideo beta
US7700751B2 (en) * 2000-12-06 2010-04-20 Janssen Alzheimer Immunotherapy Humanized antibodies that recognize β-amyloid peptide
AU2003217912A1 (en) 2002-03-01 2003-09-16 Xencor Antibody optimization
AU2004205684A1 (en) 2003-01-23 2004-08-05 Genentech, Inc. Methods for producing humanized antibodies and improving yield of antibodies or antigen binding fragments in cell culture
AU2004239233B2 (en) 2003-05-06 2009-01-08 The Scripps Research Institute Domain-exchanged binding molecules, methods of use and methods of production
BRPI0412007A (pt) * 2003-06-27 2006-08-15 Bioren Inc mutagênese look-through
JP4804357B2 (ja) * 2003-11-01 2011-11-02 メルク パテント ゲーエムベーハー 改変抗ｃｄ５２抗体
HUE038955T2 (hu) 2003-11-05 2018-12-28 Roche Glycart Ag Antigén-kötõ molekulák fokozott Fc receptor-kötõ affinitással és effektor funkcióval
GB0325817D0 (en) 2003-11-05 2003-12-10 Univ Cambridge Tech Method and apparatus for assessing polypeptide aggregation
WO2005092925A2 (en) 2004-03-24 2005-10-06 Xencor, Inc. Immunoglobulin variants outside the fc region
DE602005026706D1 (de) 2004-12-30 2011-04-14 Us Government Humanisierte col-1-antikörper mit substituierten resten am gerüst, und deren anwendung
US8029783B2 (en) 2005-02-02 2011-10-04 Genentech, Inc. DR5 antibodies and articles of manufacture containing same
DOP2006000029A (es) 2005-02-07 2006-08-15 Genentech Inc Antibody variants and uses thereof. (variantes de un anticuerpo y usos de las mismas)
RU2010116756A (ru) 2007-09-28 2011-11-10 Чугаи Сейяку Кабусики Кайся (Jp) Антитело против глипикана-3 с улучшенными кинетическими показателями в плазме
CA2727937A1 (en) 2008-06-20 2009-12-23 Massachusetts Institute Of Technology Immunoglobulins with reduced aggregation
GB0914691D0 (en) 2009-08-21 2009-09-30 Lonza Biologics Plc Immunoglobulin variants
US9209965B2 (en) 2014-01-14 2015-12-08 Microsemi Semiconductor Ulc Network interface with clock recovery module on line card

Also Published As

Publication number Publication date
IL217993A0 (en) 2012-03-29
JP5901522B2 (ja) 2016-04-13
EP2467400B1 (en) 2018-01-24
EA201290063A1 (ru) 2012-12-28
CA2771465A1 (en) 2011-02-24
AU2010284841A1 (en) 2012-03-15
SG10201404903XA (en) 2014-10-30
US20150104449A1 (en) 2015-04-16
KR20120056850A (ko) 2012-06-04
GB0914691D0 (en) 2009-09-30
US20120148568A1 (en) 2012-06-14
CN102596994A (zh) 2012-07-18
SG178340A1 (en) 2012-03-29
EP2467400A1 (en) 2012-06-27
MX2012002100A (es) 2012-06-19
US9290563B2 (en) 2016-03-22
TW201116626A (en) 2011-05-16
US8951516B2 (en) 2015-02-10
JP2013502402A (ja) 2013-01-24
DK2467400T3 (en) 2018-05-14
CN106986935A (zh) 2017-07-28
WO2011021009A1 (en) 2011-02-24

Similar Documents

Publication Publication Date Title
BR112012003571A2 (pt) método para melhorar e para avaliar a capacidade de fabricação de uma imunoglobina, método para preparar uma imunoglobulina, e, imunoglobulina variante.
BR112012002608A2 (pt) composição lubrificante, e, método para melhorar o desempenho de uma composição lubrificante.
BRPI1008021A2 (pt) Método para fabricação de 2,6-dioxabiciclo-(3.3.0)-octano-4,8-diona
BR112012003365A2 (pt) método e dispositivo para a fabricação de objetos de titânio.
BRPI0814466A2 (pt) Método.
BR112013015810A2 (pt) método de fabricação de embalagens.
BRPI1014035A2 (pt) método para contracepção.
BRPI1014650A2 (pt) molas espiral-em-espiral e molas interiores.
BR112012022433A2 (pt) Método para fabricação de um transdutor de dobra, uma microbomba e uma microválvula, microbomba e microválvula
BR112012000171A2 (pt) composição lubrificante, e, método
BR112014005411A2 (pt) invólucro de cilindro, e método para fabricar o mesmo
BRPI0813569A2 (pt) Método de inspeção.
BR112014028447A2 (pt) bolsa coletora, e, método para fabricar uma bolsa coletora.
BRPI1014710A2 (pt) equipamento para a formação de uma montagem de janela de veículo, e método para a formação de uma montagem de janela de veículo.
BRPI0910950A2 (pt) haste de perfuração, e, método para fabricar uma haste de perfuração
BRPI0924664A2 (pt) eletrodo ,e ,método para construir um eletrodo.
BRPI1011186A2 (pt) contas expandíveis, corpo moldado, e, método de produção para o mesmo
BRPI1008304A2 (pt) pistão, e, método para construir um pistão
EP2586761A4 (en) PROCESS FOR THE PREPARATION OF 2,3,3,3-TETRAFLUORPROPES
BRPI0823031A2 (pt) Conjunto, e , método para fabricar um conjunto
BRPI1001271A2 (pt) método para fabricar uma mídia de gravação óptica, e, mídia de gravação óptica.
BRPI0815796A2 (pt) Compósito elastomérico e método para produzi-lo.
BRPI1011531A2 (pt) composto, e , método para fluoração de 18f.
BRPI1014059A2 (pt) Espumas grossas para aplicações biomédicas e métodos de fabricação.
BR112012021236A2 (pt) método para produzir composição de isocianato modificada por uretonimina, e, composição de isocianato modificada por uretonimina

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]